1. Organization and Business (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 23, 2020 |
May 08, 2020 |
May 07, 2020 |
Jun. 23, 2020 |
Jun. 11, 2020 |
May 28, 2020 |
May 18, 2020 |
Apr. 30, 2020 |
Mar. 22, 2020 |
Jan. 22, 2020 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Sep. 18, 2019 |
Mar. 31, 2020 |
Dec. 31, 2019 |
Mar. 31, 2019 |
Dec. 31, 2018 |
|
| Net loss | $ (383,258,002) | $ (1,715,152) | $ (389,093,946) | $ (6,722,632) | |||||||||||||||
| Net Cash Used in Operating Activities | (2,331,260) | (2,550,140) | |||||||||||||||||
| Accumulated deficit | (456,981,465) | (456,981,465) | $ (66,047,135) | ||||||||||||||||
| Stockholders equity | 63,218,056 | 9,190,612 | 63,218,056 | 9,190,612 | $ 4,387,868 | 9,086,702 | $ 10,767,514 | $ 12,839,771 | |||||||||||
| Current assets | 58,460,486 | 58,460,486 | 4,646,249 | ||||||||||||||||
| Cash, Cash Equivalents, and Restricted Cash | 54,382,775 | $ 2,631,334 | 54,382,775 | 2,631,334 | 305,121 | $ 3,085,026 | |||||||||||||
| Current liabilities | 8,783,171 | 8,783,171 | 8,296,385 | ||||||||||||||||
| Working capital | 49,677,315 | 49,677,315 | $ (3,650,136) | ||||||||||||||||
| Warrant exercise price | $ 0.21 | ||||||||||||||||||
| Debt discount | $ 10,729,852 | 10,729,852 | |||||||||||||||||
| Proceeds from issuance of equity | $ 44,755,671 | $ 1,757,552 | |||||||||||||||||
| Proceeds from exercise of warrants | $ 5,649,319 | ||||||||||||||||||
| Warrants exercised | 29,666,283 | ||||||||||||||||||
| Investor [Member] | |||||||||||||||||||
| Proceeds from investors | $ 3,600,000 | ||||||||||||||||||
| Common Stock [Member] | |||||||||||||||||||
| Stock converted, shares converted | 65,476,190 | ||||||||||||||||||
| January 2020 Offering [Member] | Warrants [Member] | |||||||||||||||||||
| Warrants issued | 500,000 | ||||||||||||||||||
| Warrant exercise price | $ 3.90 | ||||||||||||||||||
| PPP [Member] | |||||||||||||||||||
| Proceeds from loans | $ 366,267 | ||||||||||||||||||
| Interest rate | 1.00% | ||||||||||||||||||
| Warrant Exercise Agreement [Member] | Private Transaction [Member] | |||||||||||||||||||
| Warrant exercise price | $ 0.34 | ||||||||||||||||||
| Proceeds from exercise of warrants | $ 170,000 | $ 718,879 | |||||||||||||||||
| Securities Purchase Agreement [Member] | Warrants [Member] | |||||||||||||||||||
| Stock issued new, shares | 12,000,000 | 8,000,000 | 20,000,000 | 7,500,000 | 4,000,000 | ||||||||||||||
| Proceeds from issuance of equity | $ 54,480,000 | $ 2,800,000 | $ 30,000,000 | $ 9,000,000 | $ 1,000,000 | ||||||||||||||
| Sale price, per share | $ 0.454 | $ 0.35 | $ 1.50 | $ 1.20 | $ 0.2568 | ||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Warrants issued No definition available.
|
| X | ||||||||||
- Definition Working capital No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average effective interest rate during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization, of debt discount. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received from principal payments made on loans related to operating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|